Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00005091
Status:
COMPLETED
Last Update Posted:
2013-07-10
First Post:
2000-04-06
Brief Title:
DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Sponsor:
Daiichi Pharmaceuticals
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
DAIICHI-8951E-PRT017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Daiichi Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None